Real-world circulating tumor DNA analysis depicts resistance mechanism and clonal evolution in ALK inhibitor-treated lung adenocarcinoma patients

BACKGROUND: Sequential treatment with different generations of anaplastic lymphoma kinase (ALK) inhibitors have been widely applied to ALK-positive lung cancer; however, resistance mutations inevitably developed. Further characterization of ALK resistance mutations may provide key guidance to subseq...

Descripción completa

Detalles Bibliográficos
Autores principales: Hua, G., Zhang, X., Zhang, M., Wang, Q., Chen, X., Yu, R., Bao, H., Liu, J., Wu, X., Shao, Y., Liang, B., Lu, K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818928/
https://www.ncbi.nlm.nih.gov/pubmed/35123209
http://dx.doi.org/10.1016/j.esmoop.2021.100337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818928/
https://www.ncbi.nlm.nih.gov/pubmed/35123209
http://dx.doi.org/10.1016/j.esmoop.2021.100337

Ejemplares similares